ZOVIRAX Trademark

Trademark Overview


On Thursday, June 6, 2024, a trademark application was filed for ZOVIRAX with the United States Patent and Trademark Office. The USPTO has given the ZOVIRAX trademark a serial number of 98588614. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 11, 2024. This trademark is owned by Rising Pharma Holdings, Inc.. The ZOVIRAX trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals
zovirax

General Information


Serial Number98588614
Word MarkZOVIRAX
Filing DateThursday, June 6, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, November 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAntivirals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRising Pharma Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events


Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Monday, November 11, 2024NON-FINAL ACTION E-MAILED
Monday, November 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 11, 2024NON-FINAL ACTION WRITTEN

Related Keywords


zovirax antivirals